Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 3Withdrawn 1Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 4Obesity 1Menstruation Disturbances 1

Interventions

Metformin 5Exercise 3Diet, Mediterranean 3Tamoxifen 2Surveys and Questionnaires 2Mammography 2Dexamethasone 2Counseling 2semaglutide 1lime 1exemestane 1Utrogestan 1Topiramate 1Therapeutics 1Testosterone 1Taxes 1Spironolactone 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Preoperative Exercise 1Pancreaticoduodenectomy 1Paclitaxel 1Ovidrel 1Nutritional Support 1Methods 1Magnetic Resonance Spectroscopy 1Liraglutide 1Letrozole 1Intravital Microscopy 1Immunoenzyme Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Obesity × Caloric Restriction × Clear all
NCT05702905 2024-03-25

Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome

Peking University First Hospital

Phase 4 Unknown
75 enrolled
Other

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡